PsA/SpA
Date |
Type | Title | Save |
|---|---|---|---|
| 16 Dec 2017 | Social | RT @DrPetryna: Delay in PSA Dx by >6 mo significantly increases risk of functional disability and structural damage #NYU 3rd annual seminar… | |
| 16 Dec 2017 | Social | RT @DrPetryna: Can effective treatment of psoriasis prevent onset of PSA? Prevention trial on the drawing board #psoriaticarthritis #preven… | |
| 15 Dec 2017 | News | FDA Approves Xeljanz for Use in Psoriatic Arthritis | |
| 11 Dec 2017 | News | 2017 Update of Treat to Target Recommendations for SpA/PsA | |
| 04 Dec 2017 | News | Ixekizumab (Taltz) FDA Approved for Psoriatic Arthritis | |
| 20 Nov 2017 | News | ACR17 Good News – Ankylosing Spondylitis and Spondyloarthritis | |
| 16 Nov 2017 | Social | IL-17–producing αβ T cell clones with psoriasis-specific antigen receptors exist in clinically resolved psoriatic s… https://t.co/Lj4B4dQ25N | |
| 16 Nov 2017 | Social | Check out Phil Mease's ACR17 video on Risankizumab (an IL-23 inhibitor) in Psoriatic arthritis - this was a late b… https://t.co/Vm0MbTowCt | |
| 14 Nov 2017 | Social | Smoking Paradox in PsA - a UK study shows smoking was positively related to PsA risk in the general population, but… https://t.co/N7ZEgUYHhH | |
| 13 Nov 2017 | News | MTX Doubles Hepatotoxicity Risk in Psoriasis Patients | |
| 10 Nov 2017 | Social | RT @msmassarotti: Predictors of radiographic progression in patients with nr-axSpA: conclusions from DESIR trial - R. Landewé SPARTAN-ASAS-… | |
| 10 Nov 2017 | Social | RT @synovialjoints: Bone marrow oedema in sacroiliac joints is common (30-40%) in young athletes and is most frequent in the posterior lowe… | |
| 10 Nov 2017 | Social | RT @doctorakerkar: Only 9-14% people with chronic backache see a rheumatologist #ACR17 https://t.co/jq5Y0xFjE6 | |
| 10 Nov 2017 | News | Several Agents Score on Radiographic Progression in Psoriatic Arthritis | |
| 09 Nov 2017 | Social | RT @msmassarotti: CVD risk in axSpA - Nigil Haroon SPARTAN-GRAPPA-ASAS Symposium #ACR17 https://t.co/BtpXBszcUb | |
| 09 Nov 2017 | Social | RT @japaoli19: @RheumNow Agree. Only 6% were strong recommendations. Glad they addressed comorbidities but management not necessarily consi… | |
| 09 Nov 2017 | Social | RT @rheumnews1: New PsA guideline expected in 2018. #ACR17 https://t.co/c7Y8GiBv4q https://t.co/g7wtIBXXko | |
| 09 Nov 2017 | Social | @japaoli19 These are mostly of little or low evidence, are confusing and not prescriptive and without clear financ… https://t.co/7DG9AjQ9UH | |
| 09 Nov 2017 | Social | RT @DrPetryna: Smoking paradox: smoking assoc w/⬆️risk of PsA in gen population HR1.27 but w/ ⬇️risk of PsA in PSO (HR 0.91) population-bas… | |
| 08 Nov 2017 | Social | RT @uptoTate: Come do Orange Theory w/ me! High intensity interval training may improve fatigue in PsA pts. #ACR17 @RheumNow #2968 https://… |
